Title
Category
Credits
Event date
Cost
Alzheimer’s Disease Diagnosis Time Outs: A Deep Dive into Challenging Clinical Scenarios for Early Alzheimer's Diagnosis and Treatment
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
$0.00
Program DescriptionThe management of AD is at the beginning of a seismic paradigm shift. Historically, clinical strategy has been tailored to a therapeutic armamentarium that was nonspecific and directed solely at symptom management. This mindset coincides with a variety of outdated and potentially harmful assumptions such as the idea that early diagnosis provides limited clinical value. Now that anti-Aβ antibodies are making their way into the clinic, the entire spectrum of AD care, from diagnosis through therapy, must be re-engineered.
The Age of Disease Modification in Alzheimer’s Disease: A Grand Rounds Series on the Practical Implementation of Amyloid Targeting Therapies into Clinical Practice
  • 1.00 AMA PRA Category 1 Credit™
06/19/2025
$0.00
Program DescriptionFor the first time in the history of AD management, a class of therapy designed to alter the disease course for patients is finally a reality in the form of anti-amyloid beta monoclonal antibodies (anti-Aβ mAbs). And while this development represents a monumental shift in the treatment of this progressive disease, it unlocks a whole host of new challenges for clinicians in the form of significant adjustment of practice norms.

Pages